<?xml version="1.0" encoding="UTF-8"?>
<app-group>
 <app id="app1-pharmaceuticals-13-00303">
  <title>Supplementary Materials</title>
  <p>The following are available online at 
   <uri xlink:href="https://www.mdpi.com/1424-8247/13/10/303/s1" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.mdpi.com/1424-8247/13/10/303/s1</uri>, Figure S1: Cell viability profile of HepG2 cells treated with 
   <italic>T. bentzoë</italic> extract and fractions. Figure S2: Representatives annexin V-FITC/PI flow cytometric profile of HepG2 cells, 48 h post-extract/control treatment. Figure S3: Representatives cell cycle histogram of HepG2 cells, 48 h post-extract/control treatment. Figure S4: UPLC ESI MS of the butanol fraction 6 at the positive (A) and negative (B) mode. Figure S5: 
   <sup>1</sup>H NMR spectrum (A) and HSQC spectrum (B) for punicalagin (1) in an HPLC fraction at RT 2-3 min in methanol-d
   <sub>4</sub>. Figure S6: 
   <sup>1</sup>H NMR spectra for a mixture of isoterchebulin (2), terflavin A (3), and 3,4,6-trigalloyl-beta-D-glucopyranose (4) in a HPLC fraction at RT 18-20 min in acetone-d
   <sub>6</sub> (A) and methanol-d
   <sub>4</sub> (B). Figure S7: 
   <sup>1</sup>H NMR spectra for a mixture of 2”-
   <italic>O</italic>-galloyl-orientin (3) and 2”-
   <italic>O</italic>-galloyl-isoorientin (6) with a ratio of 5:2 based on the integration of single hydrogen in each compound. Figure S8: GC-MS chromatogram of TMSi derivatives of ethyl acetate (A) and butanol (B) fraction of 
   <italic>T. bentzoë</italic>. Table S1 
   <sup>1</sup>H NMR spectral data (500 MHz, CD
   <sub>3</sub>OD) of the 
   <italic>O</italic>-galloyl-C-glycosylflavones 7 and 8 (5:2).
  </p>
 </app>
</app-group>
